CEA

Test Name
CEA
Aliases
Carcinoembryonic Antigen
Provincial Mnemonic
CARAG
LOINC Test Code
2039-6
Description and Primary Use
Not for screening. Measurement of CEA has been shown to be clinically relevant in the management of patients with colorectal, breast, lung, prostatic, pancreatic, and ovarian carcinomas.
Reorder interval
14 Days
TAT
≤3 Days
Test Cost
Not Available
Tier
1 - General Availability
Ordering Requirements (Restrictions / Conditions)

No Restrictions

Required Consultations
None
Algorithms and Guidelines

None

Special Patient Preparation

None

Special Collection / Transport / Processing Requirements

No special requirement

Criteria for Rejection

Do not use specimens that are grossly hemolyzed or pooled.

Laboratory Service Area
Clinical Chemistry
Performing Laboratory / Site
Category 4 Laboratory (HSC only)
Last Updated
28-Aug-19